Ohio lawmakers are considering legislation that would mandate insurance coverage for menopause treatment, a move that could significantly expand access to hormone therapy and other interventions for the state’s approximately 1.2 million women experiencing menopausal symptoms. The proposed bill would require health insurers operating in Ohio to cover evidence-based treatments including hormone replacement therapy, non-hormonal medications, and counseling services related to menopause management.
The legislation comes amid growing recognition that menopause care has been historically underfunded and undertreated in the American healthcare system. Many insurance plans currently classify menopause treatments as elective or cosmetic, leaving women to pay out-of-pocket for therapies that can cost hundreds of dollars monthly. Hot flashes, night sweats, mood changes, and bone density loss affect up to 80% of menopausal women, with symptoms severe enough to interfere with daily life in approximately 20% of cases.
According to The Columbus Dispatch, the bill has garnered bipartisan interest as advocates emphasize the economic impact of untreated menopause symptoms. Studies suggest that menopause-related productivity losses cost U.S. employers an estimated $1.8 billion annually through missed work days and reduced performance. Supporters argue that comprehensive insurance coverage could actually reduce overall healthcare costs by preventing complications like osteoporosis and cardiovascular disease that become more common after menopause.
If passed, Ohio would join a small but growing number of states examining menopause care coverage requirements. The legislation could set a precedent for how insurance companies approach this phase of women’s health, potentially influencing coverage decisions beyond state borders. For Ohio women currently struggling to afford menopause treatment, the bill represents hope for more equitable access to care during a transition that affects every woman who lives long enough to experience it.
